21 July 2025
Samaiden Group (SAMAIDEN MK): Bioenergy Boost For Samaiden; Keep BUY
Malaysia Company Update
Energy & Petrochemicals | Renewable Energy
Target Price (Return): MYR1.44 (13.2%)
Price (Market Cap): MYR1.27 (USD134m)
ESG score: 3.3 (out of 4)
Avg Daily Turnover (MYR/USD): 0.53m/0.12m
Analysts
Miza Izaimi
+603 2302 8121
miza.izaimi@rhbgroup.com
Sean Lim, CFA
+603 2302 8128
sean.lim@rhbgroup.com
Share Performance (%)
YTD | 1m | 3m | 6m | 12m | |
---|---|---|---|---|---|
Absolute | (1.6) | 24.5 | 23.3 | 2.4 | 2.4 |
Relative | 5.5 | 23.6 | 21.5 | 5.0 | 9.0 |
52-wk Price low/high (MYR) 0.93 – 1.33 |
SAMAIDEN MK (SAMAIDEN MK)
- Keep BUY and MYR1.44 TP (SOP), 13% upside, c.2% FY26F (Jun) yield. We reiterate our positive stance on Samaiden’s outlook following its latest win of three new bioenergy assets, which reinforce the group’s strong position in the renewable energy (RE) space. These assets further strengthen Samaiden’s diversified RE portfolio – spanning solar, biogas, and biomass – and underscore its growing role in driving Malaysia’s clean energy transition.
- Expanding asset portfolio. Samaiden, through its subsidiaries Legasi Green Resources (88% stake), Sumas Energy (51%), and SC Green Solutions (100%), has been shortlisted under the Feed-in Tariff (FiT) 2.0 programme by Sustainable Energy Development Authority (SEDA) Malaysia. The group won two biomass plants with 5.5MW and 11MW installed capacity and one biogas plant with 1.5MW installed capacity. The power purchase agreement (PPA) spans 21 years, with FiT 2.0 structured in two phases – a fixed FiT rate for the initial 10 years, followed by a competitive bidding mechanism within a tariff floor and ceiling set by SEDA for the remaining 11 years of the renewable energy power purchase agreement (RePPA).
- We maintain our earnings estimates for now, pending more details as Samaiden is still fine-tuning its costing (plant capex is generally at MYR10-12m per MW) and funding structure for this new facility. Our back-of-envelope calculations suggest that the three plants could contribute c.MYR11m in annual earnings to Samaiden, based on the group’s effective stakes in the respective projects, and could potentially be valued at around MYR0.38/share. Management is guiding for a high single-digit to low double-digit IRR. These projects are expected to be energised as early as 2028. Meanwhile, its previously secured 7MW biomass project is pending approvals from relevant authorities. Samaiden also stands to benefit from potential EPCC contracts related to other shortlisted FiT 2.0 projects.
- No change to TP and recommendation. Our SOP-derived TP of MYR1.44 is unchanged, incorporating: i) 24x CY25F P/E for its EPCC business, ii) DCF valuation (WACC of 7.8%) for its 60%-owned biogas and biomass assets, and iii) DCF (WACC of 5.9%) for its CGPP solar assets. Our TP includes a 6% ESG premium, based on Samaiden’s 3.3 ESG score (vs the country median of 3.0). We note upside potential to our valuation, as we have yet to incorporate contributions from its Large-Scale Solar 5 (LSS5) asset and newly awarded FiT 2.0 bioenergy projects, pending further clarity.
- Key risks: Discontinuation of solar incentives, competition risks, and higher-than-expected project costs.
Forecasts and Valuation
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Total turnover (MYRm) | 171 | 227 | 318 | 452 | 557 |
Recurring net profit (MYRm) | 10 | 16 | 20 | 28 | 34 |
Recurring net profit growth (%) | (16.9) | 55.3 | 24.2 | 41.6 | 19.6 |
Recurring P/E (x) | 50.78 | 32.70 | 26.34 | 18.60 | 15.56 |
P/B (x) | 5.4 | 3.9 | 3.5 | 3.1 | 2.7 |
P/CF (x) | 17.93 | na | 110.87 | 585.38 | na |
Dividend Yield (%) | 0.5 | 0.7 | 1.1 | 1.5 | 2.0 |
EV/EBITDA (x) | 30.67 | 18.61 | 14.11 | 9.59 | 7.56 |
Return on average equity (%) | 11.0 | 13.0 | 14.1 | 17.7 | 18.7 |
Net debt to equity (%) | net cash | net cash | net cash | net cash | net cash |
Overall ESG Score: 3.3 (out of 4)
E Score: 3.3 (EXCELLENT)
S Score: 3.0 (GOOD)
G Score: 3.3 (EXCELLENT)
Please refer to the ESG analysis on the next page
Note: Small cap stocks are defined as companies with a market capitalisation of less than USD0.5bn.
Emissions And ESG
Trend analysis
In FY24, Samaiden reported total greenhouse (GHG) emissions of c.382tCO2e, a 150% YoY increase due to the inclusion of Scope 3 emissions in its disclosures. Meanwhile, its Scope 1 and Scope 2 emissions saw a significant reduction, decreasing by 28% YoY.
Emissions (tCO2e) | Jun-22 | Jun-23 | Jun-24 | Jun-25 |
---|---|---|---|---|
Scope 1 | – | 88 | 25 | na |
Scope 2 | – | 65 | 85 | na |
Scope 3 | na | na | 272 | na |
Total emissions | na | 153 | 382 | na |
Latest ESG-Related Developments
Samaiden has launched a solar project at Tsun Jin High School, which includes installing a solar PV system with a capacity of about 637kWp and is estimated to avoid around 453tCO2e emissions pa.
The group has partnered with Meta Bright Group to expand business opportunities and accelerate the growth of renewable energy solutions, particularly for the Asia-Pacific mining sector.
ESG Unbundled
Overall ESG Score: 3.3 (out of 4)
Last Updated: 2 Dec 2024
E Score: 3.3 (EXCELLENT)
Samaiden ensures that it complies with environmental laws and regulations to minimise adverse impact to the environment. It is also constantly monitoring its sub-contractors and suppliers to avoid any environmental incidents and hazards. The group’s services are beneficial to the environment over the long run.
S Score: 3.0 (GOOD)
Samaiden has adopted a series of human resources policy and good practices in order to build a conducive work environment and positive workplace culture. The group also funds staff training costs to upskill them.
G Score: 3.3 (EXCELLENT)
Samaiden has applied and adopted the majority of best practices of the Malaysian Code on Corporate Governance. 33% of the board members are female and 67% of the board members are independent non-executive directors. We highlight that the group has adopted the board diversity policy, which considers its diversity in different aspects such as professional experiences, business experiences, skills, knowledge, gender, age, ethnicity, and educational background.
ESG Rating History
Financial Exhibits
Key drivers
- Demand for solar EPCC works from Commercial and Industrial projects; and
- Demand for solar EPCC works from utility-size projects
Key risks
- Dependence on Government policies and initiatives on renewable energy;
- Competition risks;
- Unexpected increase in project costs.
Valuation basis
SOP (24x P/E on CY25F FD EPCC EPS; DCF RE assets @ 7.8% WACC)
Company Profile
Samaiden is a renewable energy (RE) turnkey Engineering, Procurement, Construction and Commissioning (EPCC) services provider, providing end-to-end solutions to build renewable energy – mainly solar photovoltaic – systems from scratch. Samaiden is also striving to be the owner of RE projects.
Financial summary (MYR)
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Recurring EPS | 0.03 | 0.04 | 0.05 | 0.07 | 0.08 |
DPS | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 |
BVPS | 0.24 | 0.33 | 0.36 | 0.41 | 0.47 |
Return on average equity (%) | 11.0 | 13.0 | 14.1 | 17.7 | 18.7 |
Valuation metrics
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Recurring P/E (x) | 50.78 | 32.70 | 26.34 | 18.60 | 15.56 |
P/B (x) | 5.4 | 3.9 | 3.5 | 3.1 | 2.7 |
FCF Yield (%) | 5.2 | (1.2) | 0.5 | (0.2) | (0.5) |
Dividend Yield (%) | 0.5 | 0.7 | 1.1 | 1.5 | 2.0 |
EV/EBITDA (x) | 30.67 | 18.61 | 14.11 | 9.59 | 7.56 |
EV/EBIT (x) | 30.04 | 17.82 | 13.95 | 9.48 | 7.47 |
Income statement (MYRm)
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Total turnover | 171 | 227 | 318 | 452 | 557 |
Gross profit | 26 | 35 | 44 | 62 | 75 |
EBITDA | 14 | 22 | 28 | 39 | 46 |
Depreciation and amortisation | 0 | 1 | 0 | 0 | 1 |
Operating profit | 14 | 23 | 28 | 39 | 46 |
Net interest | (1) | (2) | (2) | (2) | (2) |
Pre-tax profit | 13 | 21 | 27 | 38 | 45 |
Taxation | (3) | (6) | (7) | (9) | (11) |
Reported net profit | 10 | 15 | 20 | 28 | 34 |
Recurring net profit | 10 | 16 | 20 | 28 | 34 |
Cash flow (MYRm)
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Change in working capital | 23.3 | (12.2) | (1.3) | 0.3 | 0.6 |
Cash flow from operations | 29.3 | (4.4) | 4.7 | 0.9 | (0.7) |
Capex | (1.8) | (2.1) | (2.0) | (2.0) | (2.0) |
Cash flow from investing activities | (0.4) | 1.8 | (2.0) | (2.0) | (2.0) |
Cash flow from financing activities | (5.6) | 22.0 | 7.6 | 10.8 | 13.6 |
Cash at beginning of period | 28.1 | 47.4 | 36.8 | 46.3 | 67.0 |
Net change in cash | 23.3 | 19.4 | 10.3 | 9.7 | 10.9 |
Ending balance cash | 51.4 | 66.8 | 47.1 | 56.1 | 77.9 |
Balance sheet (MYRm)
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Total cash and equivalents | 108 | 132 | 142 | 162 | 186 |
Tangible fixed assets | 6 | 8 | 10 | 10 | 10 |
Total assets | 195 | 205 | 220 | 259 | 281 |
Short-term debt | 5 | 7 | 7 | 7 | 7 |
Total long-term debt | 4 | 2 | 2 | 2 | 2 |
Total liabilities | 97 | 70 | 71 | 90 | 89 |
Total equity | 98 | 135 | 149 | 169 | 192 |
Total liabilities & equity | 195 | 205 | 220 | 259 | 281 |
Key metrics
Jun-23 | Jun-24 | Jun-25F | Jun-26F | Jun-27F | |
---|---|---|---|---|---|
Revenue growth (%) | 13.3 | 33.0 | 39.7 | 42.3 | 23.4 |
Recurrent EPS growth (%) | (16.9) | 55.3 | 24.2 | 41.6 | 19.6 |
Gross margin (%) | 15.1 | 15.6 | 13.9 | 13.8 | 13.4 |
Operating EBITDA margin (%) | 8.1 | 9.5 | 8.7 | 8.6 | 8.2 |
Net profit margin (%) | 5.9 | 6.6 | 6.3 | 6.2 | 6.1 |
Dividend payout ratio (%) | 27.8 | 26.0 | 28.1 | 27.8 | 31.5 |
Capex/sales (%) | 1.1 | 0.9 | 0.6 | 0.4 | 0.4 |
Interest cover (x) | 11.4 | 14.0 | 18.5 | 25.8 | 30.6 |
Figure 1: SOP valuation
Valuation method | Fully diluted value per share (MYR) | |
---|---|---|
Fully diluted CY25F EPCC earnings | 24x P/E on fully diluted CY25F EPCC EPS | 1.03 |
1.2MW Kelantan biogas asset * | 60% x DCF (21 years PPA, WACC: 7.8%) | 0.01 |
7MW biomass asset | DCF (21 years PPA, WACC: 7.8%) | 0.07 |
CGPP asset | DCF (21 years PPA, WACC: 5.9%) | 0.06 |
Cash proceeds from warrants | 0.19 | |
SOP-derived intrinsic value | 1.36 | |
+6% ESG premium | 0.08 | |
TP (MYR) | 1.44 | |
Current share base (m) | 413.2 | |
Warrants conversion (m) | 146.8 | |
Fully diluted share base (m) | 560.00 |
Recommendation Chart
Date | Recommendation | Target Price | Price |
---|---|---|---|
2025-05-27 | Buy | 1.44 | 1.04 |
2024-12-31 | Buy | 1.62 | 1.29 |
2024-12-02 | Buy | 1.33 | 1.16 |
2024-08-30 | Buy | 1.33 | 1.15 |
2024-05-24 | Buy | 1.58 | 1.39 |
2024-04-08 | Buy | 1.76 | 1.34 |
2024-02-22 | Buy | 1.46 | 1.28 |
2023-11-29 | Buy | 1.55 | 1.13 |
2023-09-01 | Buy | 1.55 | 1.28 |
2023-07-28 | Buy | 1.55 | 1.30 |
2023-07-12 | Buy | 1.29 | 1.15 |
2023-05-25 | Buy | 1.05 | 0.90 |
2023-02-06 | Buy | 1.06 | 0.82 |
2022-08-31 | Neutral | 0.76 | 0.71 |
2022-08-03 | Buy | 0.76 | 0.63 |
RHB Guide to Investment Ratings
Buy: Share price may exceed 10% over the next 12 months
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
Take Profit: Target price has been attained. Look to accumulate at lower levels
Sell: Share price may fall by more than 10% over the next 12 months
Not Rated: Stock is not within regular research coverage
Investment Research Disclaimers
RHB has issued this report for information purposes only. This report is intended for circulation amongst RHB and its affiliates’ clients generally or such persons as may be deemed eligible by RHB to receive this report and does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this report. This report is not intended, and should not under any circumstances be construed as, an offer or a solicitation of an offer to buy or sell the securities referred to herein or any related financial instruments.
RESTRICTIONS ON DISTRIBUTION
Malaysia
This report is issued and distributed in Malaysia by RHB Investment Bank Berhad (“RHBIB”). The views and opinions in this report are our own as of the date hereof and is subject to change. If the Financial Services and Markets Act of the United Kingdom or the rules of the Financial Conduct Authority apply to a recipient, our obligations owed to such recipient therein are unaffected. RHBIB has no obligation to update its opinion or the information in this report.
Indonesia
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. This research does not constitute an offering document and it should not be construed as an offer of securities in Indonesia. Any securities offered or sold, directly or indirectly, in Indonesia or to any Indonesian citizen or corporation (wherever located) or to any Indonesian resident in a manner which constitutes a public offering under Indonesian laws and regulations must comply with the prevailing Indonesian laws and regulations.
Singapore
This report is issued and distributed in Singapore by RHB Bank Berhad (through its Singapore branch) which is an exempt capital markets services entity and an exempt financial adviser regulated by the Monetary Authority of Singapore. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, RHB Bank Berhad (through its Singapore branch) accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact RHB Bank Berhad (through its Singapore branch) in respect of any matter arising from or in connection with the report.
DISCLOSURE OF CONFLICTS OF INTEREST
RHB Investment Bank Berhad, its subsidiaries (including its regional offices) and associated companies, (“RHBIB Group”) form a diversified financial group, undertaking various investment banking activities which include, amongst others, underwriting, securities trading, market making and corporate finance advisory.
Analyst Certification
The analyst(s) who prepared this report, and their associates hereby, certify that:
(1) they do not have any financial interest in the securities or other capital market products of the subject companies mentioned in this report, except for:
Analyst | Company |
---|---|
(2) no part of his or her compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed in this report.